Monthly Prescribing Reference

Butrans Transdermal System approved for chronic pain

BUTRANS (buprenorphine) 5mcg/hr, 10mcg/hr, 20mcg/hr transdermal patch by Purdue The FDA has approved Purdue's Butrans (buprenorphine) Transdermal System for the management of moderate to severe ...
Medscape

FDA Approves 7-Day Buprenorphine Pain Patch

July 8, 2010 — The US Food and Drug Administration (FDA) has approved a once-weekly buprenorphine transdermal system (Butrans; Purdue Pharma LP) for the management of moderate to severe chronic pain ...
Monthly Prescribing Reference

Butrans Transdermal System available soon for chronic pain

BUTRANS (buprenorphine) 5mcg/hr, 10mcg/hr, 20mcg/hr transdermal patch by Purdue Purdue announced that Butrans (buprenorphine) Transdermal System will be available for ordering the week of January 10, ...
Medscape

Trial Shows Safety, Efficacy of 7-Day Buprenorphine Patch in Opioid-Naive Patients

September 28, 2010 (Las Vegas, Nevada) — A transdermal application system containing the partial μ-opioid receptor agonist buprenorphine showed analgesic efficacy in the treatment of low back pain in ...
FiercePharma

Purdue Pharma L.P. Receives FDA Approval For 15 mcg/hour Dosage Strength Of Butrans® (Buprenorphine) Transdermal System CIII

STAMFORD, Conn., Sept. 24, 2013 /PRNewswire/ -- Purdue Pharma L.P. announced that the U.S. Food and Drug Administration (FDA) approved a new 15 mcg/hour dosage strength of Butrans® (buprenorphine) ...
Pharmabiz

Purdue Pharma gets US FDA nod for 15 mcg/hour dosage strength of Butrans transdermal system CIII

Purdue Pharma has received the US Food and Drug Administration (FDA) approval for a new 15 mcg/hour dosage strength of Butrans (buprenorphine) Transdermal System CIII, which will provide an additional ...
Business Wire

Elanco’s ZORBIUM™ (Buprenorphine Transdermal Solution) – the First Long-Acting Transdermal Buprenorphine for Cats - Gains U.S. Approval

GREENFIELD, Ind.--(BUSINESS WIRE)--With the U.S. Food and Drug Administration (FDA) approval of Zorbium™ (buprenorphine transdermal solution), Elanco Animal Health (NYSE: ELAN) expands its pain ...
Reuters

Luye Pharma obtains approval to commence development of Buprenorphine Transdermal patches

* Obtained approval from China Food and Drug Administration to commence development of Buprenorphine Transdermal patches in prc Source text for Eikon: Further company coverage: ...
Becker's Hospital Review

Immediate-Release Opioids Can Supplement Transdermal Buprenorphine

At a PAINWeek 2012 presentation investigators reported that immediate-release opioids are acceptable to use as supplemental analgesia in certain situations, according to the Monthly Prescribing ...
Nasdaq

Elanco’s ZORBIUM™ (Buprenorphine Transdermal Solution) – the First Long-Acting Transdermal Buprenorphine for Cats - Gains U.S. Approval

FDA issues approval for new, prescription medication to control postoperative pain associated with surgical procedures in cats, expanding Elanco’s pain portfolio. A new long-acting medication to ...
Becker's ASC

Studies Show Immediate-Release Opioids Can Supplement Transdermal Buprenorphine

At a PAINWeek 2012 presentation investigators reported that immediate-release opioids are acceptable to use as supplemental analgesia in certain situations, according to the Monthly Prescribing ...